Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report analysing the major pharmaceutical markets of the Middle East.
The rpublication Major Pharmaceutical Markets of the Middle East: An overview of Egypt, Israel, Jordan, Lebanon, Saudi Arabia & UAE (2nd Ed), reports that Middle East’s pharmaceutical market is valued at more than $12 billion and is expected to grow at healthy 10-15% annually.
Authors of the 89 page report note that growth is being forecast for the pharmaceutical and biotechnology markets of Middle Eastern states, driven by moves to liberalise national economies, the introduction of mass health insurance and the determination of the region’s governments to become self-sufficient in pharmaceuticals production.
Chapter One of the report covers the main characteristics of the Middle Eastern market through a Political, Economic, Social and Technological (PEST) analysis, plus insight into the tax environment and Free-Trade Agreements in place or being negotiated while chapter two reports on the Intellectual Property Rights environment of each of the countries covered.
Furthermore, Chapter Three provides an overview of the regional pharmaceutical market, and includes data on consumption, production, imports, exports, as well as market forecasts.
Some of the key findings of the report include:
*There are more than 450 pharmaceutical manufacturers in the Middle East – With the exception of Egypt, all Middle Eastern countries are high importers of branded drugs. Egypt is over 90% self-sufficient in its medicine needs
*Saudi Arabia, as the richest regional market, has embarked on an ambitious hospital building project – Major growth drivers are greater access to generics and innovative new medicines as primary care improves and more people are covered by health insurance.
ReportBuyer Product ID: URC00016
reportBuyer Product category: Pharma and Healthcare
Leave a Reply